Hasbro Inc. (0J3K)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 119.23 |
|---|---|
| 52-week range | 74.50 – 120.00 |
| Return, 1 month / 3 months | +36.2% / +33.7% |
| Return, 1 year / 3 years | +58.9% / +194.4% |
| Trend | Uptrend |
| RSI (14) | 87 |
| Volatility (1 year) | 31.6% |
| Worst drawdown (1 year) | -27.1% |
| Average daily value traded | 0.11M USD |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hasbro is a toy and game company based in Pawtucket, Rhode Island, in the United States. It designs and makes toys, board games and action figures, and its brands include Monopoly, Nerf, Transformers and My Little Pony. Its customers are retailers, families and children around the world, and it also licenses its characters for films, television and digital entertainment. The company sells through mass-market stores, specialty retailers and online channels across many countries.
On this site Hasbro Inc. appears as a stock on the London Stock Exchange (UK), code 0J3K, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hasbro Inc. (0J3K) trades on the London Stock Exchange in UK. It last closed at USD 119.23 on 27 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 778 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 58.9% and over the last three months it rose 33.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 30.9% | ||
| From 52-week high | 0.0% | ||
| Momentum | 83 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 33.7% | ||
| 6-month return | 27.8% | ||
| 12-month return, skipping the last month | 16.7% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.1% | ||
| Liquidity | 31 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.11M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +9.8% |
|---|---|
| 1 month | +36.2% |
| 3 months | +33.7% |
| 6 months | +27.8% |
| 1 year | +58.9% |
| 3 years | +194.4% |
| 5 years | +54.5% |
Signals
| 50-day / 200-day average | 94.88 / 91.06 |
|---|---|
| Golden / death cross (60 days) | Golden, 43 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.00 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Aug 2026 | USD 0.7000 |
| 29 May 2026 | USD 0.7000 |
| 17 Feb 2026 | USD 0.7000 |
| 18 Nov 2025 | USD 0.7000 |
| 19 Aug 2025 | USD 0.7000 |
| 20 May 2025 | USD 0.7000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.